Abstract
High and neurotoxic blood levels of leucine and its ketoanalogue develop in catabolic patients with maple syrup urine disease. The use of relatively high doses of insulin and additional glucose had a more pronounced effect on lowering leucine (and α-ketoisocaproate) blood levels than dietary elimination of leucine alone. This is demonstrated in 2 neonates after blood exchange transfusion and in one 4-months old patient suffering from febrile diarrhea.
Similar content being viewed by others
References
Beisel WR (1977) Magnitude of the host nutritional responses to infection. Am J Clin Nutr 30:1236–1247
Benson JV, Cormick J, Patterson JA (1967) Accelerated chromatography of amino acids associated with phenylketonuria, leucinosis (maple syrup urine disease) and other inborn errors of metabolism. Annal Biochem 18:481–492
Berger M, Zimmermann-Telchow H, Berchthold P, Drost H, Müller WA, Gries FA, Zimmermann H (1978) Blood amino acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism 27:793–799
Cahill GF Jr (1971) Physiology of insulin in man. Diabetes 20:785–799
Chaussain J-L, Georges P, Gendrel D, Donnadieu M, Job J-C (1980) Serum branched-chain amino acids in the diagnosis of hyperinsulinism in infancy. J Pediatr 96:923–926
Clow CL, Reade TM, Scriver CR (1981) Outcome of early and long-term management of classical maple syrup urine disease. Pediatr 68:856–862
Dancis J, Hutzler J, Snyderman SE, Cox RP (1972) Enzyme activity in classical and variant forms of maple syrup urine disease. J Pediatr 81:312–320
Felig P (1975) Amino acid metabolism in man. Ann Rev Biochem 44:933–955
Gaull GE, Tallan HH, Laijtha A, Rassin DK (1975) Pathogenesis of brain dysfunction in inborn errors of amino acid metabolism. In: Gaull GE (ed) Biology of brain dysfunction, vol 3. Plenum, New York, pp 47–143
Hammersen G, Wille L, Schmidt H, Lutz P, Bickel H (1978) Maple syrup urine disease: treatment of the acutely ill newborn. Eur J Pediatr 129:157–165
Langenbeck U, Wendel U, Luthe H (1979) Renal clearance of branched-chain 2-oxo acids in maple syrup urine disease. J Clin Chem Clin Biochem 17:176–177
Langenbeck U, Wendel U, Mench-Hoinowski A, Kuschel D, Becker K, Przyrembel H, Bremer HJ (1978) Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease. Clin Chim Acta 88:283–291
Lotspeich WD (1949) The role of insulin in the metabolism of amino acids. J Biol Chem 179:175–180
Schauder P, Schröder K, Matthaei D, Henning HV, Langenbeck U (1981) Einfluß von Insulin auf die Blutspiegel verzweigtkettiger Ketosäuren beim Menschen. In: Verhandlungen der Deutschen Gesellschaft für innere Medizin, 87. Bd. J. F. Bergmann, München, pp 962–967
Scriver C (1975) For Committee for improvement of hereditary disease management. Management of maple syrup urine disease in Canada. Can Med Assoc J 115:1005–1009
Snyderman SE (1975) Maple syrup urine disease. In: Raine DN (ed) The treatment of inherited metabolic disease. MTP, p 71
Snyderman SE, Norton PM, Roitman E, Holt LE (1964) Maple syrup urine disease, with particular reference to dieto-therapy. Pediatrics 34:454–472
Waisman HA, Smith BA, Brown ES, Gerritsen T (1972) Treatment of branched-chain ketoaciduria (BCKA) during acute illness. Approaches to the correction of the acidosis. Clin Pediatr 11:360–363
Wannemacher RW Jr (1977) Key role of various individual amino acids in host response to infection. Am J Clin Nutr 30:1269–1280
Wendel U, Becker K, Przyrembel H, Bulla M, Manegold C, Mench-Hoinowski A, Langenbeck U (1980) Peritoneal dialysis in maple-syrup urine disease: studies on branched-chain amino and keto acids. Eur J Pediatr 134:57–63
Wendel U, Langenbeck U, Lombeck I, Bremer HJ (1982) Exchange transfusion in acute episodes of maple syrup urine disease. Studies on branched-chain amino and keto acids. Eur J Pediatr 138:293–296
Woolfson AMJ, Heatley RV, Allison SP (1979) Insulin to inhibit protein catabolism after injury. N Engl J Med 300:14–17
Author information
Authors and Affiliations
Additional information
With support of the Landesamt für Forschung des Ministeriums für Wissenschaft und Forschung des Landes Nordrhein-Westfalen. U.L. was supported by Deutsche Forschungsgemeinschaft, Bad Godesberg, G.F.R. (SFB 33 and La 217)
Presented in part on the 19th Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Southampton 9–11. Sept. 1981 and in a short communication in J. Inher. Metab. Dis.
Rights and permissions
About this article
Cite this article
Wendel, U., Langenbeck, U., Lombeck, I. et al. Maple syrup urine disease-therapeutic use of insulin in catabolic states. Eur J Pediatr 139, 172–175 (1982). https://doi.org/10.1007/BF01377350
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01377350